External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

Inne Nauwelaers; Nele Laudus; Dieter Peeters; Balazs Acs; Carsten Denkert; Stefan Michiels; Hugo Horlings; Kalliopi P. Siziopikou; Scott Ely; Dimitrios Zardavas; Roberts Mustimbo; John Bartlett; Giuseppe Floris; Johan Hartman; Carolien H.M. van Deurzen; Dorien Ceusters; Els Dequeker; Roberto Salgado

doi:10.3390/cancers14153762

External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

Inne Nauwelaers, Nele Laudus, Dieter Peeters, Balazs Acs, Carsten Denkert, Stefan Michiels, Hugo Horlings, Kalliopi P. Siziopikou, Scott Ely, Dimitrios Zardavas, Roberts Mustimbo, John Bartlett, Giuseppe Floris, Johan Hartman, Carolien H.M. van Deurzen, Dorien Ceusters, Els Dequeker, Roberto Salgado^*

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Editorial › Academic › peer-review

3 Downloads (Pure)

Abstract

New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.

Original language	English
Article number	3762
Journal	Cancers
Volume	14
Issue number	15
DOIs	https://doi.org/10.3390/cancers14153762
Publication status	Published - 2 Aug 2022

Bibliographical note

Funding Information:
The training and EQC-platform have been supported by the Breast Cancer Research Foundation and Bristol-Myers Squib (CW3199227).

Publisher Copyright:
© 2022 by the authors.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/cancers14153762Licence: CC BY

External Quality Assessment 2.0 The Importance of a Standardized Implementation of TILs for Daily and Trial PracticesFinal published version, 386 KBLicence: CC BY

Cite this

Nauwelaers, I., Laudus, N., Peeters, D., Acs, B., Denkert, C., Michiels, S., Horlings, H., Siziopikou, K. P., Ely, S., Zardavas, D., Mustimbo, R., Bartlett, J., Floris, G., Hartman, J., van Deurzen, C. H. M., Ceusters, D., Dequeker, E., & Salgado, R. (2022). External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices. Cancers, 14(15), [3762]. https://doi.org/10.3390/cancers14153762

@article{4c5c5852052d453cb8997d8e5b3391b6,

title = "External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices",

abstract = "New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.",

author = "Inne Nauwelaers and Nele Laudus and Dieter Peeters and Balazs Acs and Carsten Denkert and Stefan Michiels and Hugo Horlings and Siziopikou, {Kalliopi P.} and Scott Ely and Dimitrios Zardavas and Roberts Mustimbo and John Bartlett and Giuseppe Floris and Johan Hartman and {van Deurzen}, {Carolien H.M.} and Dorien Ceusters and Els Dequeker and Roberto Salgado",

note = "Funding Information: The training and EQC-platform have been supported by the Breast Cancer Research Foundation and Bristol-Myers Squib (CW3199227). Publisher Copyright: {\textcopyright} 2022 by the authors.",

year = "2022",

month = aug,

day = "2",

doi = "10.3390/cancers14153762",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "15",

}

Nauwelaers, I, Laudus, N, Peeters, D, Acs, B, Denkert, C, Michiels, S, Horlings, H, Siziopikou, KP, Ely, S, Zardavas, D, Mustimbo, R, Bartlett, J, Floris, G, Hartman, J, van Deurzen, CHM, Ceusters, D, Dequeker, E & Salgado, R 2022, 'External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices', Cancers, vol. 14, no. 15, 3762. https://doi.org/10.3390/cancers14153762

TY - JOUR

T1 - External Quality Assessment 2.0

T2 - The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

AU - Nauwelaers, Inne

AU - Laudus, Nele

AU - Peeters, Dieter

AU - Acs, Balazs

AU - Denkert, Carsten

AU - Michiels, Stefan

AU - Horlings, Hugo

AU - Siziopikou, Kalliopi P.

AU - Ely, Scott

AU - Zardavas, Dimitrios

AU - Mustimbo, Roberts

AU - Bartlett, John

AU - Floris, Giuseppe

AU - Hartman, Johan

AU - van Deurzen, Carolien H.M.

AU - Ceusters, Dorien

AU - Dequeker, Els

AU - Salgado, Roberto

PY - 2022/8/2

Y1 - 2022/8/2

N2 - New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.

AB - New assays are developed regularly to improve health care for patients. It is important to ensure that assays are performed correctly. Therefore, it is advised to participate in training and proficiency (competence assessment) programs. Tumor infiltrating lymphocytes (TILs) might improve the estimates of response to therapy and prognosis. Herewith, we propose a new training and proficiency program in which each pathologist can train and test themselves regarding TILs (and PDL1) scoring.

UR - http://www.scopus.com/inward/record.url?scp=85136828863&partnerID=8YFLogxK

U2 - 10.3390/cancers14153762

DO - 10.3390/cancers14153762

M3 - Editorial

AN - SCOPUS:85136828863

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 15

M1 - 3762

ER -

External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this